Francesca Colavita
Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani
ORCID: 0000-0003-0640-8667Also affiliated with Istituti di Ricovero e Cura a Carattere Scientifico
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 5 papers. Top paper: “Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19”.
Alessandro Cozzi-Lepri, Francesca Colavita, Simone Lanini, Silvia Rosati, Eleonora Lalle +16 more
Elisa Pianura, Federica Di Stefano, Massimo Cristofaro, Ada Petrone, Luisa Marchioni +82 more
Martin Aimè Coussoud-Mavoungou, Francine Ntoumi, Concetta Castilletti, Lambert Kitembo, Najmul Haider +31 more
Francesca Colavita, Concetta Castilletti, Daniele Lapa, Giulia Matusali, Silvia Meschi +8 more
Zhijie Li, Reza Saberianfar, Mart Ustav, James Brett Case, Levi L. Blazer +23 more